- Home
- GERN vs GLDD Comparison
GERN vs GLDD Comparison
Compare GERN & GLDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- GLDD
- Stock Information
- Founded
- GERN 1990
- GLDD 1890
- Country
- GERN United States
- GLDD United States
- Employees
- GERN N/A
- GLDD N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- GLDD Military/Government/Technical
- Sector
- GERN Health Care
- GLDD Industrials
- Exchange
- GERN Nasdaq
- GLDD Nasdaq
- Market Cap
- GERN 823.0M
- GLDD 770.3M
- IPO Year
- GERN 1996
- GLDD 2006
- Fundamental
- Price
- GERN $1.27
- GLDD $11.97
- Analyst Decision
- GERN Buy
- GLDD Buy
- Analyst Count
- GERN 8
- GLDD 1
- Target Price
- GERN $3.71
- GLDD $14.00
- AVG Volume (30 Days)
- GERN 5.5M
- GLDD 337.0K
- Earning Date
- GERN 11-06-2025
- GLDD 11-04-2025
- Dividend Yield
- GERN N/A
- GLDD N/A
- EPS Growth
- GERN N/A
- GLDD 63.54
- EPS
- GERN N/A
- GLDD 1.06
- Revenue
- GERN $164,447,000.00
- GLDD $830,567,000.00
- Revenue This Year
- GERN $175.15
- GLDD $13.73
- Revenue Next Year
- GERN $56.61
- GLDD $3.56
- P/E Ratio
- GERN N/A
- GLDD $11.33
- Revenue Growth
- GERN 11877.20
- GLDD 24.40
- 52 Week Low
- GERN $1.09
- GLDD $7.51
- 52 Week High
- GERN $4.83
- GLDD $12.89
- Technical
- Relative Strength Index (RSI)
- GERN 41.64
- GLDD 54.66
- Support Level
- GERN $1.23
- GLDD $11.60
- Resistance Level
- GERN $1.33
- GLDD $12.32
- Average True Range (ATR)
- GERN 0.07
- GLDD 0.27
- MACD
- GERN -0.02
- GLDD 0.02
- Stochastic Oscillator
- GERN 13.79
- GLDD 58.82
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.